OKUR logo

OKUR
Onkure Therapeutics Inc

192
Mkt Cap
$164.41M
Volume
93,787.00
52W High
$5.38
52W Low
$1.70
PE Ratio
-0.92
OKUR Fundamentals
Price
$3.96
Prev Close
$4.07
Open
$4.00
50D MA
$4.13
Beta
0.92
Avg. Volume
159,531.56
EPS (Annual)
-$4.40
P/B
0.99
Rev/Employee
$0.00
$19.30
Loading...
Loading...
News
all
press releases
OnKure Therapeutics (NASDAQ:OKUR) Issues Quarterly Earnings Results
OnKure Therapeutics (NASDAQ:OKUR - Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($1.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.74) by ($0.37...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
CVS Q1 Earnings Preview: Health Services Likely to Lead Performance
CVS Health heads into Q1 earnings results with Health Services growth expected to offset pressure in benefits, as revenues dip slightly and costs remain elevated.
Zacks·7d ago
News Placeholder
OnKure Therapeutics (OKUR) Projected to Post Quarterly Earnings on Tuesday
OnKure Therapeutics (NASDAQ:OKUR) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-5-onkure-therapeutics-stock...
MarketBeat·9d ago
News Placeholder
Short Interest in OnKure Therapeutics, Inc. (NASDAQ:OKUR) Drops By 57.6%
OnKure Therapeutics, Inc. (NASDAQ:OKUR - Get Free Report) was the target of a large decrease in short interest in the month of April. As of April 15th, there was short interest totaling 69,494 shares, a decrease of 57.6% from the March 31st total of 163,904 shares. Currently, 0.5% of the shares of...
MarketBeat·11d ago
News Placeholder
TMO Q1 Earnings Preview: Will Life Sciences Solutions Lead Results?
Thermo Fisher heads into Q1 earnings with Life Sciences Solutions growth in focus, as bioproduction strength and new innovations may drive results.
Zacks·21d ago
News Placeholder
Short Interest in OnKure Therapeutics, Inc. (NASDAQ:OKUR) Increases By 1,958.6%
OnKure Therapeutics, Inc. (NASDAQ:OKUR - Get Free Report) saw a large increase in short interest in March. As of March 31st, there was short interest totaling 163,904 shares, an increase of 1,958.6% from the March 15th total of 7,962 shares. Based on an average daily volume of 786,389 shares, the...
MarketBeat·27d ago
News Placeholder
OnKure Therapeutics, Inc. (NASDAQ:OKUR) Short Interest Down 85.2% in March
OnKure Therapeutics, Inc. (NASDAQ:OKUR - Get Free Report) was the target of a significant decline in short interest in March. As of March 13th, there was short interest totaling 7,962 shares, a...
MarketBeat·1mo ago
News Placeholder
HC Wainwright Has Positive Forecast for OKUR Q1 Earnings
OnKure Therapeutics, Inc. (NASDAQ:OKUR - Free Report) - Stock analysts at HC Wainwright upped their Q1 2026 earnings per share (EPS) estimates for OnKure Therapeutics in a research note issued to...
MarketBeat·2mo ago
News Placeholder
OnKure Therapeutics (NASDAQ:OKUR) Price Target Lowered to $27.00 at HC Wainwright
HC Wainwright dropped their price objective on OnKure Therapeutics from $34.00 to $27.00 and set a "buy" rating on the stock in a research report on Monday...
MarketBeat·2mo ago
<
...
1
>

Latest OKUR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.